PrEP 211 allows greater flexibility of dosing—and is just as effective as PrEP taken daily. Read More
Andrew Caldwell explains why he decided to participate in an “intimidating” HIV cure study, and how his life changed as a result.
Cirrus embarks on a two-year HIV prevention study, along the way mulling over what might be learned—and how his participation makes a difference. Read More
Liz Highleyman summarizes the PrEP and HIV prevention research presented recently at the domestic HIV conference, CROI, including a new possible PrEP drug, real world PrEP effectiveness, and more. Read More
An engineered “three-pronged” broadly neutralizing antibody successfully blocked simian HIV in a study with monkeys. Broadly neutralizing antibody-based therapies may be used in the future for HIV prevention and/or treatment. Read More